GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Loans Receivable

Oncodesign Precision Medicine (XPAR:ALOPM) Loans Receivable

: €0.00 Mil (As of Jun. 2022)
View and export this data going back to 2022. Start your Free Trial

Oncodesign Precision Medicine's Loans Receivable for the quarter that ended in Jun. 2022 was €0.00 Mil.


Oncodesign Precision Medicine Loans Receivable Historical Data

The historical data trend for Oncodesign Precision Medicine's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21
Loans Receivable
- -

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22
Loans Receivable - - -

Oncodesign Precision Medicine Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Oncodesign Precision Medicine Loans Receivable Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines